TTOO Research and Charts

TTOO - T2 Biosystems Inc (Healthcare: Diagnostics & Research)

Projected Earnings Date: 2024-08-27 (Delayed quote data 2025-06-30)

Last 0.14	Change ⇓ 0.00 (0.00%)	Volume 43,050
	Open 0.15	High 0.16	Low 0.14

8EMA (Daily) 0.14	40EMA (Daily) 0.15	50EMA (Daily) 0.15	STO (Daily) 46.667	MACD Hist (Daily) 0.000
8EMA (Weekly) 0.143	40EMA (Weekly) 0.71	50EMA (Weekly) 0.94	STO (Weekly) 62.000	MACD Hist (Weekly) 0.140


Company Profile
T2 Biosystems Inc provides rapid in vitro diagnostic tests to hospitals and laboratories. The company's core technology is T2 Magnetic Resonance (T2MR) technology, which can detect a variety of molecular targets directly from whole blood. T2MR technology enables the T2Dx system, which is fully automated from patient sample to result for its panels focused on bacterial and fungal infections that could cause sepsis, and its pipeline panel for Lyme disease.

Disclaimer: All information provided is for informational purposes only and not intended for trading purposes or advice. The quotes and charts are not real time and have delays of at least 20 minutes. Data accuracy cannot be guaranteed as errors will occur. Please do not rely on the above information to make your stock/option trades. Neither OptionChance.com nor any of independent data providers is liable for any informational errors, incompleteness, or delays, or for any actions taken in reliance on information contained herein.